October 31, Brief summaries of each expert s significant conclusions regarding the epidemiological and toxicological data are provided below.
|
|
- Esmond Hart
- 6 years ago
- Views:
Transcription
1 VIA Dear Members of the European Commission, Parliament and Member States, This letter contains a link to six expert scientist 1 reports explaining the connection between glyphosate-based formulations ( GBFs ) and the cancer Non-Hodgkin Lymphoma ( NHL ). The reports were written for lawsuits pending against Monsanto Company in the United States 2 and compile epidemiology, toxicology, and oncology evidence important for regulators like the European Commission to assess, along with the Monsanto Papers, when determining whether to extend or restrict the use of GBFs in Europe. Brief summaries of each expert s significant conclusions regarding the epidemiological and toxicological data are provided below. We are expecting more documents from the ongoing U.S. litigation to be de-classified in the near future, a number of which pertain to communications between Bfr, BVL, EFSA, and Monsanto that may of interest to European lawmakers. Epidemiological Data Shows GBFs Induce NHL Numerous independent studies find statistically significant elevated risks between exposure to GBFs and NHL, and those studies which do not find statistically significant risks still consistently observe an elevated risk. Dr. Ritz conducted a comprehensive literature search 1 Dr. Beate Ritz, Chair of the Epidemiology Department at the University of California, Los Angeles ( UCLA ); Dr. Alfred I. Neugut, Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, New York; Dr. Christopher Portier, former Associate Director of the National Toxicology Program; Dr. Jameson, former Program Leader for the National Toxicology Program; Dr. Chadi Nabhan, board-certified clinical medical oncologist specializing in lymphomas and past Assistant Professor of Medicine at the University of Chicago, currently serving as Medical Director of Cardinal Health, Dublin, Ohio; Dr. Dennis D. Weisenberger, Chair of the Pathology Department of the City of Hope Medical Center, Omaha, Nebraska, specializing in NHL. 2 In Re Roundup Products Liability Litigation, 3:16-md-2741-VC, Federal Court for the Northern District of California.
2 Page 2 and presented a chart in her report (attached) which demonstrates that of the 32 GBF/NHL epidemiology studies, 28 showed a higher risk of NHL for persons exposed to GBFs. In statistical terms, 28 of the Odd Ratios (ORs) 3 are higher than 1 4, indicating a consistently elevated risk associated with glyphosate exposure. Ritz Rpt. at 14. If there were no risk of GBFs causing NHL, one would expect to see an equal distribution of ORs above and below 1. Portier Rpt. at 15 ( [I]f the true underlying risk ratio was 1 (no effect), you would expect about half of the findings to be below 1 and half to be equal to 1 or greater.); Neugut Rpt. at 22 ( [I]f the two phenomena were truly random, then the measured associations in the studies should have randomly distributed themselves around 1. ). Here, we see the opposite. Overall the studies are pointing in the same direction toward a positive effect. Neugut Rpt. at 22. The probability of so many studies showing an elevated risk in the absence of GBFs actually inducing NHL is extremely remote. Moreover, the EFSA previously dismissed the available epidemiological data and concluded that [a]part from the Agricultural Health Study, there were no other large studies with good quality data for many study outcomes. Scientific Opinion of the PPR Panel on the follow-up of the findings of the External Scientific Report Literature review of epidemiological studies linking exposure to pesticides and health effects at 21:974. The Agricultural Health Study ( AHS ) has been relied upon by Monsanto for the contention that glyphosate does not cause cancer. However, Dr. Ritz noted several methodological limitations with the AHS such as: 1) a short period of time between enrolment of participants to follow up (when participants are asked about their disease status). This did not allow sufficient time between exposure to GBFs and potential cancer incidence (the latency period ). Ritz Rpt. at 20; 2) the study had the smallest sample size of any study reviewed, Id. at 21, which calls into question the precision of its point estimates; and 3) given that the first enrollees were providing data in 1993, two years before a substantial increase in glyphosate use, while later enrollees provided data two years after the increased use (1997), the time-varying exposure creates non-differential misclassification which biases the results towards the null. Ritz Rpt. at 8, 22; Neugut Rpt. at 13. When the available case-control studies are considered in conjunction with the published meta-analyses, there is an observed positive association between exposure to GBFs and NHL. See Ritz Rpt. at 16; Neugut Rpt. at An odds ratio, or OR, is a measure of association between an exposure and a disease. It represents the odds that the disease will occur in a group of people given a particular exposure, in comparison to the odds of the disease in a group of people without the exposure. Ritz Rpt. at represents a null finding, meaning no association between exposure to GBFs and NHL. Odds Ratios greater than 1.0 ( to the right of 1.0 ), such as 1.5, 1.7, 2.0 indicate an increased risk of NHL for individuals exposed to GBFs compared to those who have not.
3 Page 3 Reliance on an Unpublished AHS Draft Manuscript to Overcome Problems with the Original AHS Study Is Invalid Monsanto obtained an incomplete, unpublished, preliminary 96-page draft analysis of AHS and has been encouraging regulators and the general public to reject IARC s findings in favor of the unfinished draft manuscript. This version has not been published due to its flaws. In the incomplete manuscript, the AHS researchers attempted to address the original AHS analysis problems. The researchers conducted follow-up questionnaires to get more up-to-date exposure information to address the original studies exposure limitations. Unfortunately, nearly 40% of the original study participants did not respond; thus, only about 60% of the exposure data was updated. To fix this new problem, the researchers then imputed data from the people who did respond. This is improper: Ritz Reb. Rep. at 4. While under some, limited circumstances it is an acceptable epidemiological approach to impute or guestimate certain unavailable data, one must be extremely careful when imputing/guestimating a critical piece of data, such as exposure... The validity of the results of such an imputation/guestimation become extremely questionable because when applied, the study authors need to assume glyphosate/gbf use was based on historical use, and do not apply the increased use for any person who did not report their pesticide use, i.e. the nonresponders. These significant errors in the draft manuscript highlight the pitfalls of relying on unpublished material. Monsanto encouraging agencies like EFSA, BfR, ECHA, and the EPA, as well as the scientific community, to rely on the results of the unpublished, flawed data is disingenuous and misleading. No regulators should allow their licensing decisions to be based on such unreliable data. Significant Carcinogenicity Findings Within the Toxicological Data A review of the toxicological literature by analyzing animal bioassays led Dr. Portier to conclude that glyphosate has been demonstrated to cause cancer in two strains of rats and one strain of mice. Portier Rpt. at 51. Moreover, Dr. Jameson determined that in CD-1 mice, glyphosate exposure causes kidney tumors in males in two separate studies, hemangiosarcomas in males in two separate studies, malignant lymphoma in males in two separate studies, adenocarcinomas of the lung in males in one study, and hemangiosarcomas in females in one study. Jameson Rpt. at 29. Significantly, neither the EFSA, EChA nor EPA analyzed the supplemental data presented in Greim et al. (2015). The decisions of these agencies are based on the summary tumors reported by industry, not the study authors. Dr. Portier, by contrast, reviewed every data point in the Greim appendix and considered primary and secondary tumors in his analysis. Portier Rpt. at 50 (table 15); Portier Reb. Rpt. at 37 (modified table 15). Following such
4 Page 4 exhaustive analysis, Dr. Portier was able to conclude that glyphosate probably causes NHL based on the human, animal and experimental evidence and that, to a reasonable decree of scientific certainty, the probability that glyphosate causes NHL is high. Portier Reb. Rpt. at 24. It is imperative that European regulatory agencies and lawmakers are presented with transparent and reliable evaluations of the scientific data on GBFs and cancer. We hope that a review of the above experts opinions will contribute to the protection of the health of Europeans. Best, BAUM HEDLUND ARISTEI & GOLDMAN, P.C. Enclosures By: Michael L. Baum, Esq. Pedram Esfandiary, Esq. R. Brent Wisner, Esq.
5
Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process
Glyphosate Cancer Risks and Failures of the Pesticide Regulatory Process Christopher J. Portier, Ph.D. 11 October, 2017 Brussels, Belgium Disclosures The opinions expressed here and the analyses done to
More informationOverview of this case:
Overview of this case: Overview of this case: Overview of this case: Overview of this case: Not the first lawsuit: How the trial works: 1. Opening statements 2. Plaintiff s case 3. Monsanto s case 4. Rebuttal
More informationConsiderations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate
Considerations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate by Peter Clausing, PAN Germany Hamburg - April 2016 Introduction Much of the controversy
More informationEFSA Statement regarding the EU assessment of glyphosate and the socalled
EFSA Statement regarding the EU assessment of glyphosate and the socalled Monsanto papers Background On 29 May 2017, EFSA received a request from the European Commission to produce a statement concerning
More informationCase 3:16-md VC Document 1137 Filed 02/16/18 Page 1 of 20
Case :-md-0-vc Document Filed 0// Page of 0 HOLLINGSWORTH LLP Joe G. Hollingsworth (pro hac vice) Eric G. Lasker (pro hac vice) Martin C. Calhoun (pro hac vice) Heather A. Pigman (pro hac vice) 0 I Street,
More informationGlyphosate and Cancer Buying Science
Glyphosate and Cancer Buying Science Glyphosate and Cancer Buying Science Quality? Glyphosate and Cancer Buying Science Quality? Influence? Glyphosate and Cancer Buying Science Quality? Influence? BfR
More informationBAuA Federal Institute for Occupational Safety and Health Federal Office for Chemicals Friedrich-Henkel-Weg Dortmund, Germany
BAuA Federal Institute for Occupational Safety and Health Federal Office for Chemicals Friedrich-Henkel-Weg 1-25 44149 Dortmund, Germany RE: CLH Report for Glyphosate, EC Number 213-997-4 Dear Sirs, Below
More informationGlyphosate: Get the Facts NEPPSC
Glyphosate: Get the Facts NEPPSC January 8, 2019 Timothy Pastoor, PhD, DABT, ATS Pastoor Science Communications, LLC I am not affiliated with Monsanto, Bayer or any entity with interests in glyphosate
More informationCase 3:16-md VC Document Filed 10/28/17 Page 1 of 38 EXHIBIT 96
Case 3:16-md-02741-VC Document 655-6 Filed 10/28/17 Page 1 of 38 EXHIBIT 96 Case 3:16-md-02741-VC Document 655-6 Filed 10/28/17 Page 2 of 38 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
More informationThe Carcinogenicity of Glyphosate Kate Z. Guyton, PhD DABT
The Carcinogenicity of Glyphosate Kate Z. Guyton, PhD DABT Conflict of Interest Statement I declare no financial interests related to the subject matter of my presentation. IARC Evaluation of Glyphosate
More informationEvaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment
Evaluation of Ramazzini Institute Aspartame Studies and EFSA s Assessment Lisa Y. Lefferts, MSPH Senior Scientist Center for Science in the Public Interest Who is CSPI and What is Our Agenda? CSPI is a
More informationGlyphosate and Cancer Risk. Jeffrey Jenkins, Ph.D. Department of Environmental and Molecular Toxicology Oregon State University
Glyphosate and Cancer Risk Jeffrey Jenkins, Ph.D. Department of Environmental and Molecular Toxicology Oregon State University Cancer and Human Health Cancer is considered the most severe health condition
More informationMemo n 24: Peter CLAUSING. Toxicologist, Germany. The Hague, October 15 th -16 th, 2016
Memo n 24: Peter CLAUSING Toxicologist, Germany The Hague, October 15 th -16 th, 2016 CONTACTS : emilie@monsanto-tribunal.org witnesses@monsanto-tribunal.org 1 Dr. Peter Clausing, born in 1950, graduated
More informationECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate
ECHA Committee for Risk Assessment: Evaluation of the Classification and Labelling of Glyphosate Tim Bowmer, Committee Chairman Ari Karjalainen, Dossier Manager for Glyphosate 10 May 2017 1 Established
More informationGlyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies
Glyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies David A. Eastmond Environmental Toxicology Graduate Program University of California, Riverside Glyphosate
More informationSUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF SAN FRANCISCO. Plaintiff, Defendants. / Proceedings held on Friday, July 13, 2018,
SUPERIOR COURT OF THE STATE OF CALIFORNIA COUNTY OF SAN FRANCISCO DEWAYNE JOHNSON, Plaintiff, vs. MONSANTO COMPANY, et al., Case No. CGC--0 Defendants. / Proceedings held on Friday, July,, Volume, Afternoon
More informationBENZENE LITIGATION: AN OVERVIEW JOHN TOMLINSON
BENZENE LITIGATION: AN OVERVIEW JOHN TOMLINSON WHAT IS BENZENE? Benzene, also known as benzol, is a hydrocarbon liquid and an effective solvent. Highly flammable, colorless, with a sweet odor. Benzene
More informationApplication of human epidemiological studies to pesticide risk assessment
Workshop What does the future hold for harmonised human health risk assessment of plant protection products? Application of human epidemiological studies to pesticide risk assessment Antonio F. Hernández,
More informationCarcinogenicity of Glyphosate The IARC Monographs. Dana Loomis PhD Deputy Head Monographs Programme
Carcinogenicity of Glyphosate The IARC Monographs Dana Loomis PhD Deputy Head Monographs Programme Overview What are the IARC Monographs? How are IARC Monograph evaluations done? IARC evaluation of pesticides
More informationCase 3:16-md VC Document Filed 10/27/17 Page 1 of 176 EXHIBIT 38
Case 3:16-md-02741-VC Document 649-8 Filed 10/27/17 Page 1 of 176 EXHIBIT 38 Case 3:16-md-02741-VC Document 649-8 Filed 10/27/17 Page 2 of 176 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
More informationCase 3:16-md VC Document Filed 10/28/17 Page 1 of 13 EXHIBIT 56
Case 3:16-md-02741-VC Document 652-10 Filed 10/28/17 Page 1 of 13 EXHIBIT 56 Case 3:16-md-02741-VC Document 652-10 Filed 10/28/17 Page 2 of 13 149 Commonwealth Drive Menlo Park, CA 94025 Meta-Analysis
More informationCase 3:16-md VC Document Filed 01/11/19 Page 1 of 34 EXHIBIT 4
Case 3:6-md-0274-VC Document 2479-4 Filed 0//9 Page of 34 EXHIBIT 4 Case 3:6-md-0274-VC Document Chadi 2420-5 2479-4 Nabhan, Filed M.D. 0//9 0/03/9 Page 2 of 34 UNITED STATES DISTRICT COURT 2 NORTHERN
More informationINITIAL STATEMENT OF REASONS TITLE 27, CALIFORNIA CODE OF REGULATIONS
INITIAL STATEMENT OF REASONS TITLE 27, CALIFORNIA CODE OF REGULATIONS PROPOSED AMENDMENT TO: SECTION 25705(b) SPECIFIC REGULATORY LEVELS POSING NO SIGNIFICANT RISK GLYPHOSATE SAFE DRINKING WATER AND TOXIC
More informationCase 3:16-md VC Document 1596 Filed 07/10/18 Page 1 of 68 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
Case 3:16-md-02741-VC Document 1596 Filed 07/10/18 Page 1 of 68 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA IN RE: ROUNDUP PRODUCTS LIABILITY LITIGATION MDL No. 2741 Case No. 16-md-02741-VC
More informationPlease find enclosed Dosimetry Service Licence No which replaces Dosimetry Service Licence No
Directorate of Nuclear Substance Regulation Telephone: 1 (888) 229-2672 April 12, 2017 Licence Number Christopher Passmore Landauer Inc. 2 Science Road Glenwood, IL 60425-1586 Subject: Dosimetry Service
More informationCancer case hinges on Hardell testimony Jeffrey Silva
From http://www.rcrnews.com/article/20020603/sub/206030715&searchid=73326559381603 Cancer case hinges on Hardell testimony Jeffrey Silva Story posted: June 3, 2002-5:59 am EDT WASHINGTON-In the three months
More informationRe: Selection of Fluoride for Consideration for Listing by the Carcinogen Identification Committee
",,,,,+.~ "Rvr~ ~.. ~ ':::"ze." DEPARTMENT OF HEALTH & HUMAN SERVICES SEP - 6 2011 Silver Spring, MD 20993 Ms. Cynthia Oshita Office of Environmental Health Hazard Assessment Proposition 65 Implementation
More informationMonsanto s Spin on its Roundup herbicide is Unwinding
Monsanto s Spin on its Roundup herbicide is Unwinding By: Thomas T. Dunbar, Esq. Recently, information about the potential danger posed by Monsanto s Roundup has surfaced as a result of information discovered
More informationThe use of epidemiological data for pesticide risk assessment
The use of epidemiological data for pesticide risk assessment Dr. Gerard Swaen, Maastricht University, representing European Crop Protection Association (ECPA) Presentation outline 1. Industry s contribution
More informationRe: Bayer s false and deceptive marketing for its Men s Multis for prevention of cancer
June 18, 2009 VIA REGULAR MAIL AND FAX TO 973-254-4853 Gary S. Balkema, President Consumer Care Division Bayer HealthCare LLC 36 Columbia Rd Morristown, NJ 07962-1910 Re: Bayer s false and deceptive marketing
More informationA case study in risk assessment: aspartame
A case study in risk assessment: aspartame Herman B.W.M.Koëter Managing Director,, Brussels, Belgium Thanks to Dr Iona Pratt of the Irish Food Safety Authority for use of a number of the slides in this
More informationChemical food safety in the U.S. analysis of FDA s scientific basis for assessing chemical risk. Tom Neltner October 9, 2014
Chemical food safety in the U.S. analysis of FDA s scientific basis for assessing chemical risk Tom Neltner October 9, 2014 Topics 1. Current focus of U.S. public interest community 2. Comparison of U.S.
More informationPractical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings
Version 2 Updated on 29/11/2011 Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings Valid as of: 11 September 2011 Disclaimer: This
More informationComments DRAFT Preamble to the IARC Monograph. Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214
Comments DRAFT Preamble to the IARC Monograph Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214 The International Union, UAW affirms the importance of the
More informationPesticide risk assessment: changes and perspectives for mammalian toxicology in the new EC regulation 1107/2009
Pesticide risk assessment: changes and perspectives for mammalian toxicology in the new EC regulation 1107/2009 M.Tiramani Pesticide Risk Assessment Peer Review (PRAPeR) Mammalian toxicology New Pesticide
More informationAn analysis of the use of animals in predicting human toxicology and drug safety: a review
An analysis of the use of animals in predicting human toxicology and drug safety: a review Dr Elisabeth Harley Understanding Animal Research Summary Two papers published in the journal Alternatives to
More informationRegulatory Toxicology and Pharmacology
Regulatory Toxicology and Pharmacology 63 (2012) 440 452 Contents lists available at SciVerse ScienceDirect Regulatory Toxicology and Pharmacology journal homepage: www.elsevier.com/locate/yrtph Epidemiologic
More informationAddendum to the 12th Report on Carcinogens
Addendum to the 12th Report on Carcinogens Published by the U.S. Department of Health and Human Services, National Toxicology Program The twelfth edition of the National Toxicology Program (NTP) Report
More informationLawrence Martin, M.D., FACP, FCCP UHHS-Mentor 9000 Mentor Avenue Mentor, Ohio
Lawrence Martin, M.D., FACP, FCCP UHHS-Mentor 9000 Mentor Avenue Mentor, Ohio 44060 440-974-4442 December 27, 2004 Dr. Edward Abraham Editor, American Journal of Respiratory and Critical Care Medicine
More informationCarcinogenicity of Diesel Exhaust: Old and New Technology Diesel
April 5-7, 2016 Carcinogenicity of Diesel Exhaust: Old and New Technology Diesel Katherine Walker Senior Scientist Health Effects Institute Boston, MA Who is the Health Effects Institute? An independent,
More informationperpetuate -- and perhaps even intensify -- that controversy. 1 On July 18th, the Fifth Circuit affirmed FDA s longstanding position that
Food & Drug July 29, 2008 Fifth Circuit Rules that FDA May Regulate Compounded Drugs as New Drugs Update on Medical Center Pharmacy v. Mukasey For decades, the pharmacy compounding industry has disputed
More informationRenewal Assessment Report
Renewal Assessment Report 31 August 2015 Glyphosate Addendum 1 to RAR Assessment of IARC Monographs Volume 112 (2015): Glyphosate RMS: Germany - i - Glyphosate Version history 31 August 2015 Version history
More informationFood Additives Program
U.S. FDA s Food Additive Program: An Update on Resources and Challenges 18 th Food Packaging Law Seminar October 11, 2017 Arlington, VA 1 Food Additives Program Dennis Keefe, PhD Director, Office of Food
More informationTitle: Scientific principles for the identification of endocrine disrupting chemicals a consensus statement
Title: Scientific principles for the identification of endocrine disrupting chemicals a consensus statement Outcome of an international expert meeting organized by the German Federal Institute for Risk
More informationContiTech North America
ContiTech North America Dear Customer: Certain products now contain the following warning language about certain chemicals or compounds that may be found in Continental ContiTech s products or component
More informationProposition 65 and Supplements
Proposition 65 and Supplements Nutrition Industry Association John Venardos Senior Vice President Worldwide Regulatory & Government Affairs Herbalife International of America, Inc. 5/23/2011 SYNOPSIS Now
More informationDecember 4, 2017 VIA ELECTRONIC SUBMISSION
VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement
More informationBias Elimination in Forensic Science to Reduce Errors Act of 2016
American Academy of Forensic Sciences American Society of Crime Laboratory Directors International Association for Identification International Association of Forensic Nurses National Association of Medical
More informationCase 3:16-md VC Document Filed 10/27/17 Page 1 of 102 EXHIBIT 10
Case 3:16-md-02741-VC Document 648-10 Filed 10/27/17 Page 1 of 102 EXHIBIT 10 Case 3:16-md-02741-VC Document 648-10 Filed 10/27/17 Page 2 of 102 Case 3:16-md-02741-VC Document 648-10 Filed 10/27/17 Page
More informationEach copy of any part of a JSTOR transmission must contain the same copyright notice that appears on the screen or printed page of such transmission.
Decision-Making under Uncertainty in the Setting of Environmental Health Regulations Author(s): James M. Robins, Philip J. Landrigan, Thomas G. Robins, Lawrence J. Fine Source: Journal of Public Health
More information1 (17) D(2017)2270. Helsinki 08 August Global2000 Helmut Burtscher, Peter Clausing, and Claire Robinson. Global 2000 s report on glyphosate
1 (17) Helsinki 08 August 2017 D(2017)2270 GD/JdB Global2000 Helmut Burtscher, Peter Clausing, and Claire Robinson Subject: Global 2000 s report on glyphosate Further to our initial response (published
More informationHazard Assessment of Glyphosate Carcinogenicity and Reproductive Toxicity
Hazard Assessment of Glyphosate Carcinogenicity and Reproductive Toxicity Mark Martens, PhD, ERT on behalf of the Glyphosate Task Force (GTF) RAC Meeting, Helsinki December 7, 2016 Content Genotoxicity
More informationRecent Developments and Future Plans in the EFSA Assessments of Pesticides. Hermine Reich Pesticides Unit
Recent Developments and Future Plans in the EFSA Assessments of Pesticides Hermine Reich Pesticides Unit Pesticides Unit and Panel activities Scientific Panel on Plant Protection Product and their Residues
More informationI. Framework. A. All materials must be reviewed by the NOSB. B. Inert ingredient is a misleading term. November 4, 2011
November 4, 2011 National Organic Standards Board Fall 2011 Meeting Savannah, GA Comments on Inerts Discussion Document Dear Board Members: Below we present our thinking on the inert ingredients in substances
More informationBfR Proposal for a Harmonised Procedure for Estimating the Dermal Absorption
FEDERAL INSTITUTE FOR RISK ASSESSMENT BfR Proposal for a Harmonised Procedure for Estimating the Dermal Absorption Lars Niemann Why is an accurate estimate of dermal absorption so critical? Exposure of
More informationSUPERIOR COURT OF THE COUNTY OF SAN. Plaintiff, Defendants. / Proceedings held on Thursday, July 12, 2018, Suzanne R. Bolanos, at 9:23 a.m.
SUPERIOR COURT OF THE COUNTY OF SAN DEWAYNE JOHNSON, Plaintiff, STATE OF CALIFORNIA FRANCISCO vs. MONSANTO COMPANY, et al., Case No. CGC--0 Defendants. / Proceedings held on Thursday, July, 1, Volume,
More informationAlliance for Food and Farming. The Real Danger of the Dirty Dozen List: Perspectives for Journalists
Alliance for Food and Farming The Real Danger of the Dirty Dozen List: Perspectives for Journalists The Organizer Marilyn Dolan Executive Director Alliance for Food and Farming Webinar Tips Alliance for
More informationDieldrin and cancer concerns on the Bellarine Peninsula
Dieldrin and cancer concerns on the Bellarine Peninsula Community information, February 2019 This community information sheet provides a summary of the historic use of dieldrin, testing of dieldrin levels
More informationAccelerating the Pace of Chemical Risk Assessments
Accelerating the Pace of Chemical Risk Assessments An International Workshop Hosted by the US EPA September 14-15, 2016 in Washington DC Robert Kavlock, US EPA European Commission Scientific Conference
More informationAVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First-Line Advanced RCC
FOR IMMEDIATE RELEASE AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First-Line Advanced RCC - Tivozanib is the First Agent to Demonstrate Greater than One Year
More informationPREPERATION OF TURKEY TO EFSA ACTIVITIES
REPUBLIC OF TURKEY PREPERATION OF TURKEY TO EFSA ACTIVITIES Nergiz ÖZBAĞ DG - Protection and Control Ministry of Agriculture And Rural Affairs-TURKEY nergizo@kkgm.gov.tr 04 November 2010, Antalya Content
More informationHybrid Coating Technologies Newsletter
Hybrid Coating Technologies Newsletter 2nd Qtr 2017 Issue No. 1 Photos below of the team at HCT and our recent attendance at the highly productive European Coatings Show. Letter from the CEO "Due to the
More informationUNIVERSITY OF CALIFORNIA, BERKELEY 2020 LRDP FINAL EIR 11.2B REGIONAL & LOCAL AGENCY COMMENTS 11.2B.6 RESPONSE TO COMMENT LETTER B6 RESPONSE TO COMMENTS B6-1 THRU B6-3 See Thematic Response 8 for a comprehensive
More informationMissing data in clinical trials: a data interpretation problem with statistical solutions?
INTERVIEW SERIES Clin. Invest. (2012) 2(1), 11 17 Missing data in clinical trials: a data interpretation problem with statistical solutions? Robert Hemmings and David Wright speak to Laura Harvey, Assistant
More informationWELLPOINT RESPONDS TO ANCO s COMMENTS
WELLPOINT RESPONDS TO ANCO s COMMENTS Thank you again for taking the time to meet with us to learn about Anthem s Cancer Care Quality Program and the Wellpoint Cancer Treatment Pathways as well as your
More informationWithdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for
This document is scheduled to be published in the Federal Register on 12/14/2018 and available online at https://federalregister.gov/d/2018-27098, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND
More informationJudicial conflict between Bristol-Myers Squibb Co V. Merck & Co Inc. Keytruda V. Opdivo
From the SelectedWorks of haitham atiyah Spring April 10, 2016 Judicial conflict between Bristol-Myers Squibb Co V. Merck & Co Inc. Keytruda V. Opdivo haitham atiyah Available at: https://works.bepress.com/haitham_atiyah/3/
More informationUsing new scientific knowledge to update regulations in the U.S.
Using new scientific knowledge to update regulations in the U.S. Maricel Maffini, Ph.D. Food Packaging Forum 5 October, 2017 US Food Additives Regulatory Program Administered by the Food and Drug Administration
More informationFAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009
FAQ FOR THE NATA AND APTA JOINT STATEMENT ON COOPERATION: AN INTERPRETATION OF THE STATEMENT September 24, 2009 Introduction The NATA considers the Joint Statement on Cooperation a very positive resolution
More informationYours sincerely, C. Guilhem de Seze EFSA Head of Department of Scientific Evaluation of Regulated Products. de Bruijn ECHA Director of Risk Management
Overall EFSA and ECHA are of the opinion that all the findings on the chronic rodent carcinogenicity studies referred to in your letter have been adequately considered and therefore we see no need for
More informationInvestigator Initiated Study Proposal Form
Please submit completed form to IISReview@KCI1.com Date Submitted Name & Title Institution Address Phone Number Email Address Principal Investigator / Institution YES NO Multi Center Study Acelity Product(s)
More informationEvaluation of an application to use Fullerene C 60 as a food additive
Evaluation of an application to use Fullerene C 60 as a food additive Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian
More informationTestimony of. Eric J. Cassell, M.D., M.A.C.P. Member, National Bioethics Advisory Commission. and. Clinical Professor of Public Health
Testimony of Eric J. Cassell, M.D., M.A.C.P Member, National Bioethics Advisory Commission and Clinical Professor of Public Health Cornell University Medical College Before the Subcommittee on Criminal
More informationDear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good
PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion
More informationUNIVERSITY OF CALIFORNIA, LOS ANGELES
UNIVERSITY OF CALIFORNIA, LOS ANGELES BERKELEY DAVIS IRVINE LOS ANGELES MERCED RIVERSIDE SAN DIEGO SAN FRANCISCO UCLA SANTA BARBARA SANTA CRUZ DEPARTMENT OF EPIDEMIOLOGY SCHOOL OF PUBLIC HEALTH CAMPUS
More informationPHARMACOLOGY AND TOXICOLOGY MANAGEMENT OF CDER CARCINOGENICITY ASSESSMENT COMMITTEE (CAC) AND EXECUTIVE CAC CONTENTS
MANUAL OF POLICIES AND PROCEDURES CENTER FOR DRUG EVALUATION AND RESEARCH MAPP 7412.1 PHARMACOLOGY AND TOXICOLOGY MANAGEMENT OF CDER CARCINOGENICITY ASSESSMENT COMMITTEE (CAC) AND EXECUTIVE CAC CONTENTS
More informationRESEARCH RESEARCH RESEARCH Answering the Questions of Society Utilizing the Sociological Research Methodology
RESEARCH RESEARCH RESEARCH Answering the Questions of Society Utilizing the Sociological Research Methodology Marshall High School Sociology Mr. Cline Unit Two AE * Choosing a Research Design and Collecting
More informationThe WHO International EMF Project: The road ahead
Radiation Research Trust Conference 8-9 October 2008, London The WHO International EMF Project: The road ahead Dr E. van Deventer Team Leader Radiation Programme 1 Outline Who we are What we do Completed
More informationA survey of the effectiveness of the Female Genital Mutilation Training offered by the Bristol Safeguarding Children Board (BSCB)
A survey of the effectiveness of the Female Genital Mutilation Training offered by the Bristol Safeguarding Children Board (BSCB) 11 th November 2013 Page 1 11 th November 2013 Jackie Mathers Designated
More informationSeptember 2, Re: State Boards, Commissions and Authorities -- Certification of Psychologists -- Computerized Psychological Tests
September 2, 1983 ATTORNEY GENERAL OPINION NO. 83-110 Ms. Mary Ann Gabel Executive Secretary Behavioral Sciences Regulatory Board 535 Kansas, Room 1102 Topeka, Kansas 66603 Re: State Boards, Commissions
More informationThe MASCC Guidelines Policy
The MASCC Guidelines Policy Recommendations for MASCC Guideline Construction and the Endorsement of Externally Generated Guidelines Preamble MASCC recognizes that providing supportive care facilitates
More informationNew Directions California. Prevention Panel
New Directions California Prevention Panel Jeffery N. Wilkins, M.D., DFAPA, FASAM Lincy / Heyward-Moynihan, Chair in Addiction Medicine Vice Chair, Dept. of Psychiatry Cedars-Sinai Med Center Professor,
More informationUse of Standards in Substantial Equivalence Determinations
Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration
More informationOur additional criticisms of the study are based on the evidence available to us:
SEARCH There are many assertions made, and scientific conclusions drawn, about how agriculture, including fish farming, horticulture and forestry, should develop over the next half century. The purpose
More informationPre Accession Programme support and Capacity Building
Pre Accession Programme support and Capacity Building Andrea Gross-Bošković Director of Croatian Food Agency 64 th meeting of the EFSA Advisory Forum Parma, 7 8 June 2017 History 2006. IPA Pre- Accession
More informationRedesigning the Process for Establishing the Dietary Guidelines for Americans
FOOD AND NUTRITION BOARD Redesigning the Process for Establishing the Dietary Guidelines for Americans EMBARGOED UNTIL SEPTEMBER 14, 2017 AT 11AM ET BACKGROUND Dietary guidance has evolved over time from
More informationQuestions and Answers on Candidates for Substitution
Questions and Answers on Candidates for Substitution Rev. 1, January 2015 Background The European Commission is required by Regulation (EC) No 1107/2009 ( the Regulation ) to establish a list of substances
More informationEmerging Issues in Food and Drug Law: Implementation of FDASIA Innovative Drug Approvals: Breakthrough Therapies Arnold & Porter LLP, Washington DC
Emerging Issues in Food and Drug Law: Implementation of FDASIA Innovative Drug Approvals: Breakthrough Therapies Arnold & Porter LLP, Washington DC Ryan M. Hohman, JD, MPA Managing Director, Friends of
More informationEvidence-based environmental decisions: Bridging the gap between epidemiology and risk assessment
Evidence-based environmental decisions: Bridging the gap between epidemiology and risk assessment Carol J. Burns, Ph.D. Burns Epidemiology Consulting, LLC Judy S. LaKind, Ph.D. LaKind Associates, LLC University
More informationCITY OF LOS ANGELES CALIFORNIA
JUNELAGMAY City Clerk HOLLY L. WOLCOTT Executive Officer When making inquiries relative to this matter, please refer to the Council File No. CITY OF LOS ANGELES CALIFORNIA ANTONIO R. VILLARAIGOSA MAYOR
More informationCorporate Medical Policy Investigational (Experimental) Services
Corporate Medical Policy Investigational (Experimental) Services File Name: Origination: investigational_(experimental)_services 1/1996 Description of Procedure or Service BCBSNC defines the terms "investigational"
More informationFINAL. Recommendations for Update to Arsenic Soil CTL Computation. Methodology Focus Group. Contaminated Soils Forum. Prepared by:
A stakeholder body advising the Florida Department of Environmental Protection FINAL Recommendations for Update to Arsenic Soil CTL Computation Prepared by: Methodology Focus Group Contaminated Soils Forum
More informationInternational EMF Policy Developments
International EMF Policy Developments Presentation Overview Background to the MMF Recent International EMF Developments Regulations/Standards: India China Russian Federation Scientific Reviews Conclusions
More informationFalse Positives & False Negatives in Cancer Epidemiology
False Positives & False Negatives in Cancer Epidemiology David Kriebel University of Massachusetts Lowell Torino, 2 Ottobre 2008 First Context Most causes of most cancers are largely unknown. Do you agree?
More informationJanuary To: All Local CRN CHAPTERS
To: All Local CRN CHAPTERS January 2011 Re: Policies and Procedures for Operation as an Affiliated Local Chapter of the National Kidney Foundation s Council on Renal Nutrition (NKF-CRN) and new Local Chapter
More informationMethodology for the VoicesDMV Survey
M E T R O P O L I T A N H O U S I N G A N D C O M M U N I T I E S P O L I C Y C E N T E R Methodology for the VoicesDMV Survey Timothy Triplett December 2017 Voices of the Community: DC, Maryland, Virginia
More informationNIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement
NIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement The aim of these procedures is to set out the processes for applications to the NIIM Human Research Ethics
More informationSodium Reduction Strategies: State-level Opportunities. Jill Birnbaum Vice President, State Advocacy & Public Health
Sodium Reduction Strategies: State-level Opportunities Jill Birnbaum Vice President, State Advocacy & Public Health 1 AHA 2020 impact goal By 2020, to improve the cardiovascular health of all Americans
More informationEFSA Info Session Pesticides 26/27 September Anja Friel EFSA Pesticides Unit (Residues team)
Scientific Guidance Document of the PPR Panel on the establishment of the residue definition to be used for dietary risk assessment (EFSA-Q-2013-01001) EFSA Info Session Pesticides 26/27 September 2016
More informationSecretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director
COUNCIL OF THE EUROPEAN UNION Brussels, 13 February 2014 (OR. en) 6438/14 COVER NOTE From: date of receipt: 3 February 2014 To: No. Cion doc.: PHARM 14 SAN 72 MI 161 COMPET 107 DELACT 29 Secretary-General
More information